Skip to main content
Journal of Family & Reproductive Health logoLink to Journal of Family & Reproductive Health
. 2019 Sep;13(3):167–172.

Relationship Between Serum Vitamin D Level and Ectopic Pregnancy: A Case-Control Study

Farnaz Sahhaf 1, Somaiyeh Saiyar-Sarai 1, Reza Piri 2,3, Sahar Mohammadi 4,5, Mohammad Naghavi-Behzad 6,7
PMCID: PMC7072032  PMID: 32201492

Abstract

Objective: To compare the difference in Vitamin D level between women with ectopic pregnancy and control group.

Materials and methods: In the present case-control study, 150 patients with ectopic pregnancy were included as case group and 150 women with normal pregnancy as a control group. Then, serum vitamin D levels were measured in both groups and they were then compared with each other. P less than 0.05 was considered statistically significant.

Results: The mean age in ectopic pregnancy group was 28.12 ± 5.91 and 27.35 ± 6.21 years old in control group; the difference between two groups was not statistically significant (p = 0.43). The vitamin D level in control group was higher than that of ectopic pregnancy group (p = 0.002). Of all patients, 182 patients (60.66%) had vitamin D deficiency and 64 patients (21.33%) had vitamin D insufficiency.

Conclusion: Serum vitamin D level among patients with ectopic pregnancy was statistically lower than women with normal pregnancy.

Key Words: Ectopic Pregnancy, Vitamin D Deficiency, Pregnancy

Introduction

Ectopic pregnancy is known as one of the main morbidity and mortality causes among women. The prevalence of ectopic pregnancy ranges from 11 to 20 cases in 1000 live births in the developed countries (1). The risk of ectopic pregnancy rises significantly among patients with a prior history of ectopic pregnancy, smoking, pelvic inflammatory disease, miscarriage and age more than 35 years old (2). Almost all ectopic pregnancies occur in the fallopian tube (98%) (3). A number of factors such as lectin, integrin, matrix-degrading cumulus, prostaglandins, growth factors, cytokines, and modular proteins may lead to premature implantation in the fallopian tube (4).

Vitamin D is a fat-soluble vitamin with hormonal features. Vitamin D has a prominent and well-known role in calcium hemostasis and bone metabolism, also it has some non-classic features such as anti-carcinogenic features (5, 6). Vitamin D receptors are found in many body systems such as immune system, cardiovascular system and even genitourinary system (7). In the female reproductive system, vitamin D receptors are found in endometrium, ovaries and placenta proposing a possible role of vitamin D in the female reproductive system (8). The depth of implantation of the gestational sac varies according to the location of the ectopic pregnancy within the fallopian tube (9). Vitamin D insufficiency is known to be associated with gestational diabetes, endometriosis, polycystic ovary syndrome, preterm labor and pre-eclampsia (10-12). It has been reported that a lot of people worldwide suffer vitamin D insufficiency (13, 14). Vitamin D synthesis in skin is not sufficient for daily needs, so additional vitamin D intake via daily meals or supplements are recommended (15).

So considering the burden of ectopic pregnancy imposes to the health care systems and also the financial burden imposed to the families and health care systems, in the present study, it was aimed to investigate the role of vitamin D in ectopic pregnancy.

Materials and methods

In the present case-control study, which was conducted in the biggest referral center of northwest Iran during February 2014 to February 2016 (24 months), patients with ectopic pregnancy were included in the study. Of all patients, 150 patients with ectopic pregnancy confirmed using ultrasonographic report were randomly included in the study. Considering sample number limitation, sample size was calculated using [n =(/2+)² p(1-p)/ᵋ²] formula based on α=0.05 and ε=0.2. Also, after including the patients, power of study was calculated as 0.85.

On the other hand, 150 patients were selected among age-matched normal pregnant women as the control group; this group was selected to conduct comparison of vitamin D serum level.

Of all patients attending at referral centers of northwest Iran, 150 patients were selected randomly among pregnant 18-35 year-old pregnant women with ectopic pregnancy, who were in their first trimester of pregnancy. Patients with a history of smoking, diabetes, other endocrine disorders, chronic renal diseases, pelvic inflammatory disease, failed sterilization, abortion, cesarean, infertility, using intra-uterine devices, and history of hospitalization in past 1 year were excluded from the study. Demographic information consisted of age, parity and gestational age at diagnosis was obtained using patients’ records.

Of all patients, 5 cc of blood sample was obtained using winged butterfly system during first trimester after that ectopic pregnancy was confirmed, then it was transferred to a heparinized bottle. It was sent to the laboratory immediately. In the laboratory, Abbott's Architect 25-OH Vitamin D Assay (Abbott Architect, DiaSorin Liaison and AB SCIEX API 4000 (LC-MS/MS)) was used to determine vitamin D serum level within 0-160 ng/mL range. Vitamin D level more than 30 ng/mL was defined as sufficient, 20-30 ng/mL as insufficient and less than 20 ng/mL as deficient levels.

The research question was developed in response to the discussions in Iran about the required plans for treatment of Vitamin D deficiency before pregnancy in order to prevent possible ectopic pregnancies. Patients were asked to check Vitamin D level beside routine laboratory analysis. No representative of patient organizations participated in the design of the study. The results will be considered reproducible among women and in health care systems.

All participants were provided with an informed written consent to be signed. The study protocol was in compliance with the Helsinki Declaration and was approved by the Ethics Committee of Tabriz University of Medical Sciences (Tabriz, Iran). In all stages of study patient’s information was anonymous and based on codes and patients could refuse to take part in the study at any stages.

Statistical analysis was performed by SPSS software package, version 16.0, for Windows (SPSS Inc.). Quantitative data are presented as mean ± standard deviation (SD), while qualitative data are demonstrated as frequency and percentage (%). Chi-square trend (using a 2×3 table) was used for data analysis. P value less than 0.05 was considered statistically significant. Normal distribution of data was assessed using Kolmogorov-Smirnov test.

Results

In the present study, 150 patients with ectopic pregnancy (ectopic pregnancy group) and 150 age-matched pregnant women (control group) were included in the study. There was no significant difference between age, parity, Body mass index, history of vitamin D supplementation and gestational age of patients in ectopic pregnancy and control groups (Table 1).

Table 1.

Demographic factors in study groups

Study Groups Ectopic
Pregnancy
Control P
Factors
Age (y) 28.12 ± 5.91 27.35 ± 6.21 0.43
Parity 1.97 ± 0.92 2.12 ± 0.65 0.25
Body mass index
(kg/m2)
25.81 ± 4.11 24.52 ± 6.91 0.56
Vitamin D supplementation (%) 59 (39.33) 65 (43.33) 0.48
Gestational Age (w) 8.72 ± 3.57 7.90 ± 3.11 0.13

Data was shown as Mean ± Standard Deviation

There was a significant difference between vitamin D level in normal pregnancy (23.77 ± 10.49 ng/mL) and ectopic pregnancy (15.03 ± 6.54 ng/mL) groups (p < 0.001, Figure 1).

Figure 1.

Figure 1

Scatterplot graph of Vitamin D levels between Normal and Ectopic Pregnancy groups (p < 0.001)

The level of serum vitamin D was categorized into 3 groups: normal (more than 30 ng/mL), insufficient (20-30 ng/mL) and deficient (less than 20 ng/mL). Categorization of patients based on vitamin D level is shown in Table 2; vitamin D level in the control group was statistically higher than those in the ectopic pregnancy group (p = 0.002).

Table 2.

Serum vitamin D level among patients included in study

Study Groups Ectopic Pregnancy Control Total P
Vitamin D level
Vitamin D level (ng/mL) Normal (> 30) 18 (6) 36 (12) 54 (18) 0.002
Insufficient (20-30) 20(6.66) 44 (14.66) 64 (21.33)
Deficient (< 20) 102 (37.33) 70 (23.33) 182 (60.66)

Data was shown as Frequency (%)

Of all patients, 182 patients (60.66%) had vitamin D deficiency and 64 patients (21.33%) had vitamin D insufficiency. Only 54 patients (18%) had normal vitamin D level. Mean age among patients with normal, insufficient, and deficient vitamin D level was 27.28 ± 3.25, 28.52 ± 6.39, and 29.68 ± 5.75 years old, respectively; this difference among mean age of vitamin D level categories was not statistically significant (p = 0.52).

Discussion

Vitamin D is a fat-soluble vitamin that is naturally present in very few foods, added to others, and available as a dietary supplement (16). Vitamin D promotes calcium absorption in the intestines and maintains adequate serum calcium and phosphate concentrations to enable normal mineralization of bone and to prevent hypocalcemic conditions (17, 18). Vitamin D has other roles in the body, including modulation of cell growth, neuromuscular and immune function, and reduction of inflammation. Serum concentration of 25-hydroxide D is the best indicator of vitamin D status (19). It reflects cutaneous vitamin D was produced and obtained from food intake (20). Vitamin D has been proven to be a potent regulator of several cytokines and growth factors, including activin-A and interleukin-6, which contribute crucial roles in the processes of endometrial receptivity and embryo implantation (21-23). Recently, there has been an increasing evidence on the role of vitamin D in female reproductive system. It has been shown that abnormal expression of vitamin D metabolising and signalling systems by tubal epithelial cells could result in tubal gestation, possibly by inducing promoting tubal receptivity and/or abnormal tubal peristalsis (24).

Based on the current study, 123 of 140 patients (82%) did not had sufficient level of vitamin D. based on report by Bassir et al. about prevalence of vitamin D deficiency among Iranian population, it was shown that about 85 percent of mothers had levels lower than 25 ng/mL of vitamin D at term delivery (25); this is similar to what our study has indicated although our assessments were conducted in early pregnancy.

In a study by Gordon et al. about the prevalence of vitamin D deficiency among adult healthy American individuals, it was shown that 42 percent of patients were vitamin D deficient (26); this is far less than what was found in present study.

In a study by Van der Meer et al. about the prevalence of vitamin D deficiency among pregnant women categorized based on their ethnic groups it was concluded that the mean western women vitamin D level was 3-fold more than that among non-western women (27); this was similar to what presented in current study as our patients were also considered as non-western. This lower level of vitamin D has been proposed to be related to lower socioeconomic status, lower sun light exposure and poor dietary habits, but no worldwide consensus has been made about the possible reason for vitamin D deficiency (28).

As the main result of the present study, it was found that vitamin D level among patients with ectopic pregnancy was statistically lower than those with normal pregnancy (P=0.002). In a study by Ozkan et al about the effects of vitamin D level on the success rate of in vitro fertilization, it was concluded that women with higher serum level of vitamin D are significantly more likely to achieve conception following in vitro fertilization by transferring embryo. So vitamin D supplementation was suggested to increase treatment success rate among infertile patients undergoing in vitro fertilization (29); this is similar to what reported in the present study that patients with ectopic pregnancy were found to have a less serum vitamin D level.

Based on animal and experimental studies, blockage of vitamin D receptors in rats led to immature follicular evaluation, gonadal malfunction, low aromatase function level, adverse pregnancy consequences, infertility and uterine hyperplasia (30). Also, a role of vitamin D in the immunologic interaction between placenta and maternal tissue has been proposed, this role has been formed in a way that it facilitates implantation of the embryo in decidualized endometrial tissue (31). So, any defect in process of vitamin D supplementation may prevent proper implantation of the embryo, which is the mainstay of ectopic pregnancy.

In a study by Ott et al. about relationship between vitamin D level and fertility status on polycystic ovarian syndrome, it was found that vitamin D deficiency was an independent predictive factor of stimulation with clomiphene outcome, in term pregnancy and follicle development (32); just like present study as vitamin D insufficiency was associated with malfunctioned implantation, this study also presents vitamin D as a parameter for infertility.

The present study was conducted in a society with a low mean level of serum vitamin D, which might be considered as a limitation for the current study to be conducted in such a community. Another limitation of the present study is low population included in the study; by performing such a study with a higher population it is possible to make a more precise and extendible conclusion.

Conclusions

In conclusion, serum vitamin D level among patients with an ectopic pregnancy was statistically lower than women with normal pregnancy. This result can be used as an outline to perform further studies by investigating the role of vitamin D in prevention of ectopic pregnancy, such as performing interventional studies by administering vitamin D supplements to decrease ectopic pregnancy.

Acknowledgments

This study is resulted from a thesis registered at Tabriz University of Medical Sciences (Tabriz, Iran) with registration number of 95/3-5/1 which was supported by Women's Reproductive Health Research Center of Tabriz University of Medical Sciences (Tabriz, Iran).

Conflict of Interests

Authors have no conflict of interests.

Notes:

Citation: Sahhaf F, Saiyar-Sarai S, Piri R, Mohammadi S, Naghavi-Behzad M. Relationship Between Serum Vitamin D Level and Ectopic Pregnancy: A Case-Control Study. J Fam Reprod Health 2019; 13(3): 167-72.

References

  • 1.Marion LL, Meeks GR. Ectopic pregnancy: history, incidence, epidemiology, and risk factors. Clin obstet Gynecol. 2012;55:376–86. doi: 10.1097/GRF.0b013e3182516d7b. [DOI] [PubMed] [Google Scholar]
  • 2.Clayton HB, Schieve LA, Peterson HB, Jamieson DJ, Reynolds MA, Wright VC. Ectopic pregnancy risk with assisted reproductive technology procedures. Obstet Gynecol. 2006;107:595–604. doi: 10.1097/01.AOG.0000196503.78126.62. [DOI] [PubMed] [Google Scholar]
  • 3.Mol F, Mol BW, Ankum WM, Van der Veen F, Hajenius PJ. Current evidence on surgery, systemic methotrexate and expectant management in the treatment of tubal ectopic pregnancy: a systematic review and meta-analysis. Hum reprod update. 2008;14:309–19. doi: 10.1093/humupd/dmn012. [DOI] [PubMed] [Google Scholar]
  • 4.Soriano D, Hugol D, Quang NT, Darai E. Serum concentrations of interleukin-2R (IL-2R), IL-6, IL-8, and tumor necrosis factor alpha in patients with ectopic pregnancy. Fertil Steril. 2003;79:975–80. doi: 10.1016/s0015-0282(02)04853-7. [DOI] [PubMed] [Google Scholar]
  • 5.Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams L, et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney int. 2007;71:31–8. doi: 10.1038/sj.ki.5002009. [DOI] [PubMed] [Google Scholar]
  • 6.Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck A, Theiler R, et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. Bmj. 2009;339:b3692. doi: 10.1136/bmj.b3692. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Yamada S, Shimizu M, Yamamoto K. Vitamin D receptor. Vitamin D and Rickets. Karger Publishers. 2003;6:50–68. doi: 10.1159/000072769. [DOI] [PubMed] [Google Scholar]
  • 8.Grundmann M, von Versen-Höynck F. Vitamin D-roles in women's reproductive health? Reprod Biol Endocrinol. 2011;9:146. doi: 10.1186/1477-7827-9-146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Evans KN, Bulmer JN, Kilby MD, Hewison M. Vitamin D and placental-decidual function. J Soc Gynecol Investig. 2004;11:263–71. doi: 10.1016/j.jsgi.2004.02.002. [DOI] [PubMed] [Google Scholar]
  • 10.Miyashita M, Koga K, Izumi G, Sue F, Makabe T, Taguchi A, et al. Effects of 1,25-Dihydroxy Vitamin D3 on Endometriosis. J Clin Endocrinol Metab. 2016;101:2371–9. doi: 10.1210/jc.2016-1515. [DOI] [PubMed] [Google Scholar]
  • 11.Wehr E, Trummer O, Giuliani A, Gruber HJ, Pieber TR, Obermayer-Pietsch B. Vitamin D-associated polymorphisms are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome. Eur j Endocrinol. 2011;164:741–9. doi: 10.1530/EJE-11-0134. [DOI] [PubMed] [Google Scholar]
  • 12.McDonnell SL, Baggerly KA, Baggerly CA, Aliano JL, French CB, Baggerly LL, et al. Maternal 25(OH)D concentrations ≥40 ng/mL associated with 60% lower preterm birth risk among general obstetrical patients at an urban medical center. PLOS ONE. 2017;12:e0180483. doi: 10.1371/journal.pone.0180483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Devereux G, Litonjua AA, Turner SW, Craig LC, McNeill G, Martindale S, et al. Maternal vitamin D intake during pregnancy and early childhood wheezing. AM J Clin Nutr. 2007;85:853–9. doi: 10.1093/ajcn/85.3.853. [DOI] [PubMed] [Google Scholar]
  • 14.Wei SQ, Qi HP, Luo ZC, Fraser WD. Maternal vitamin D status and adverse pregnancy outcomes: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2013;26:889–99. doi: 10.3109/14767058.2013.765849. [DOI] [PubMed] [Google Scholar]
  • 15.Ahn J, Yu K, Stolzenberg-Solomon R, Simon KC, McCullough ML, Gallicchio L, et al. Genome-wide association study of circulating vitamin D levels. Hum Mol Genet. 2010;19:2739–45. doi: 10.1093/hmg/ddq155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911–30. doi: 10.1210/jc.2011-0385. [DOI] [PubMed] [Google Scholar]
  • 17.Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266–81. doi: 10.1056/NEJMra070553. [DOI] [PubMed] [Google Scholar]
  • 18.Abreu MT, Kantorovich V, Vasiliauskas E, Gruntmanis U, Matuk R, Daigle K, et al. Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn’s disease patients with elevated 1, 25-dihydroxyvitamin D and low bone mineral density. Gut. 2004;53:1129–36. doi: 10.1136/gut.2003.036657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D status. Osteoporos Int. 2005;16:713–6. doi: 10.1007/s00198-005-1867-7. [DOI] [PubMed] [Google Scholar]
  • 20.Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab . 2011;96:53–8. doi: 10.1210/jc.2010-2704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Woeckel VJ, Van der Eerden BC, Schreuders‐Koedam M, Eijken M, Van Leeuwen JP. 1α, 25‐dihydroxyvitamin D3 stimulates activin A production to fine‐tune osteoblast‐induced mineralization. J Cell Physiol. 2013;228:2167–74. doi: 10.1002/jcp.24388. [DOI] [PubMed] [Google Scholar]
  • 22.Pojednic RM, Ceglia L, Lichtenstein AH, Dawson-Hughes B, Fielding RA. Vitamin D receptor protein is associated with interleukin-6 in human skeletal muscle. Endocrine. 2015;49:512–20. doi: 10.1007/s12020-014-0505-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Refaat B, Ashshi AM, Batwa SA, Ahmad J, Idris S, Kutbi SY, et al. The prevalence of Chlamydia trachomatis and Mycoplasma genitalium tubal infections and their effects on the expression of IL-6 and leukaemia inhibitory factor in Fallopian tubes with and without an ectopic pregnancy. Innate Immun. 2016;22:534–45. doi: 10.1177/1753425916662326. [DOI] [PubMed] [Google Scholar]
  • 24.Refaat B, Ahmad J, Idris S, Kamfar FF, Ashshi AM, Batwa SA, et al. Characterisation of vitamin D-related molecules and calcium-sensing receptor in human Fallopian tube during the menstrual cycle and in ectopic pregnancy. Cell Tissue Res. 2017;368:201–13. doi: 10.1007/s00441-016-2519-2. [DOI] [PubMed] [Google Scholar]
  • 25.Bassir M, Laborie S, Lapillonne A, Claris O, Chappuis MC, Salle BL. Vitamin D deficiency in Iranian mothers and their neonates: a pilot study. Acta Paediatr. 2001;90:577–9. [PubMed] [Google Scholar]
  • 26.Gordon CM, DePeter KC, Feldman HA, Grace E, Emans S. Prevalence of vitamin d deficiency among healthy adolescents. Arch Pediatr Adolesc Med. 2004;158:531–7. doi: 10.1001/archpedi.158.6.531. [DOI] [PubMed] [Google Scholar]
  • 27.van der Meer IM, Karamali NS, Boeke AJ, Lips P, Middelkoop BJ, Verhoeven I, et al. High prevalence of vitamin D deficiency in pregnant non-Western women in The Hague, Netherlands. Am J Clin Nutr. 2006;84:350–3. doi: 10.1093/ajcn/84.1.350. [DOI] [PubMed] [Google Scholar]
  • 28.Anderson JL, May HT, Horne BD, Bair TL, Hall NL, Carlquist JF, et al. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol. 2010;106:963–8. doi: 10.1016/j.amjcard.2010.05.027. [DOI] [PubMed] [Google Scholar]
  • 29.Ozkan S, Jindal S, Greenseid K, Shu J, Zeitlian G, Hickmon C, et al. Replete vitamin D stores predict reproductive success following in vitro fertilization. Fertil Steril. 2010;94:1314–9. doi: 10.1016/j.fertnstert.2009.05.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Kovacs CS. Vitamin D in pregnancy and lactation: maternal, fetal, and neonatal outcomes from human and animal studies. Am J Clin Nutr. 2008;88:520S–8S. doi: 10.1093/ajcn/88.2.520S. [DOI] [PubMed] [Google Scholar]
  • 31.Gitto E, Reiter RJ, Karbownik M, Tan Dx, Gitto P, Barberi S, et al. Causes of oxidative stress in the pre-and perinatal period. Biol Neonate. 2002;81:146–57. doi: 10.1159/000051527. [DOI] [PubMed] [Google Scholar]
  • 32.Ott J, Wattar L, Kurz C, Seemann R, Huber JC, Mayerhofer K, et al. Parameters for calcium metabolism in women with polycystic ovary syndrome who undergo clomiphene citrate stimulation: a prospective cohort study. Eur J Endocrinol. 2012;166:897–902. doi: 10.1530/EJE-11-1070. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Family & Reproductive Health are provided here courtesy of Tehran University of Medical Sciences

RESOURCES